| RE50594 |
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors |
Andreas Gollner, Joachim BROEKER, Nina Kerres, Christiane Kofink, Juergen Ramharter +4 more |
2025-09-23 |
| 11814380 |
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors |
Juergen Ramharter, Christiane Kofink, Heinz Stadtmueller, Tobias Wunberg, Marco Hofmann +9 more |
2023-11-14 |
| 10882866 |
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors |
Andreas Gollner, Joachim BROEKER, Nina Kerres, Christiane Kofink, Juergen Ramharter +4 more |
2021-01-05 |
| 10717742 |
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors |
Andreas Gollner, Joachim BROEKER, Nina Kerres, Christiane Kofink, Juergen Ramharter +4 more |
2020-07-21 |
| 8334383 |
Regioselective preparation of substituted pyrimidines |
Adil Duran, Joerg Halmer, Michael Konrad |
2012-12-18 |
| 8329695 |
Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide |
Guenter Linz, Peter Sieger, Rolf Schmid |
2012-12-11 |
| 8222402 |
Preparation process |
Kathrin Pachur, Guenther Huchler, Michael Konrad, Kathrin Maier, Werner Rall +2 more |
2012-07-17 |